These results suggested that BPAF might accelerate the progression of breast cancer by directly promoting the growth of SK-BR-3 tumor and worsen the condition of breast cancer patients by indirectly affecting other main organs, which could be related to the activation of a novel estrogen member receptor GPER1 in a non-genomic way. The gene discussed is GPER1; the disease is neoplasm.